Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis
- 30 May 2006
- journal article
- research article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 194 (5), 1283-1289
- https://doi.org/10.1016/j.ajog.2005.11.041
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Social and sexual risk factors for bacterial vaginosisSexually Transmitted Infections, 2004
- Managing recurrent bacterial vaginosisSexually Transmitted Infections, 2004
- Association between Acquisition of Herpes Simplex Virus Type 2 in Women and Bacterial VaginosisClinical Infectious Diseases, 2003
- Bacterial Vaginosis: Review of Treatment Options and Potential Clinical Indications for TherapyClinical Infectious Diseases, 1999
- Bacterial vaginosis and disturbances of vaginal floraAIDS, 1998
- Role of bacterial vaginosis–associated microorganisms in endometritisAmerican Journal of Obstetrics and Gynecology, 1996
- Metronidazole Combined with Nystatin (Vagitories) in the Prevention of Bacterial Vaginosis after Initial Treatment with Oral MetronidazoleGynecologic and Obstetric Investigation, 1993
- A Case–Control Study of Chorioamnionic Infection and Histologic Chorioamnionitis in PrematurityThe New England Journal of Medicine, 1988
- Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partnerBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- ANAEROBIC VAGINOSIS (NON-SPECIFIC VAGINITIS): CLINICAL, MICROBIOLOGICAL, AND THERAPEUTIC FINDINGSThe Lancet, 1983